0001567619-23-007516.txt : 20231019 0001567619-23-007516.hdr.sgml : 20231019 20231019161736 ACCESSION NUMBER: 0001567619-23-007516 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06c FILED AS OF DATE: 20231019 DATE AS OF CHANGE: 20231019 EFFECTIVENESS DATE: 20231019 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Akari Therapeutics Plc CENTRAL INDEX KEY: 0001541157 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 981034922 STATE OF INCORPORATION: X0 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-495231 FILM NUMBER: 231334917 BUSINESS ADDRESS: STREET 1: 22 BOSTON WHARF ROAD STREET 2: FL 7 CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: (646) 350-0702 MAIL ADDRESS: STREET 1: 22 BOSTON WHARF ROAD STREET 2: FL 7 CITY: BOSTON STATE: MA ZIP: 02210 FORMER COMPANY: FORMER CONFORMED NAME: Celsus Therapeutics Plc. DATE OF NAME CHANGE: 20130621 FORMER COMPANY: FORMER CONFORMED NAME: Morria Biopharmaceuticals PLC DATE OF NAME CHANGE: 20120201 D 1 primary_doc.xml X0708 D LIVE 0001541157 Akari Therapeutics Plc 22 BOSTON WHARF ROAD FL 7 BOSTON MA MASSACHUSETTS 02210 (646) 350-0702 UNITED KINGDOM None Celsus Therapeutics Plc. Morria Biopharmaceuticals PLC Other Public company with limited liability incorporated under laws of England and Wales. true Rachelle Jacques Akari Therapeutics, Plc 22 Boston Wharf Road, FL 7 Boston MA MASSACHUSETTS 02210 Executive Officer Director President and Chief Executive Officer of Issuer Dr. Ray Prudo Akari Therapeutics, Plc 22 Boston Wharf Road, FL 7 Boston MA MASSACHUSETTS 02210 Director Michael Grissinger Akari Therapeutics, Plc 22 Boston Wharf Road, FL 7 Boston MA MASSACHUSETTS 02210 Director Donald Williams Akari Therapeutics, Plc 22 Boston Wharf Road, FL 7 Boston MA MASSACHUSETTS 02210 Director Wa'el Hashad Akari Therapeutics, Plc 22 Boston Wharf Road, FL 7 Boston MA MASSACHUSETTS 02210 Director Wendy DiCicco Akari Therapeutics, Plc 22 Boston Wharf Road, FL 7 Boston MA MASSACHUSETTS 02210 Executive Officer Interim Chief Financial Officer of the Issuer Other Health Care Decline to Disclose 06c false 2023-10-04 false true true true true American Depositary Shares (ADS), each representing 2,000 Ordinary Shares underlying ADS; Warrants, including underlying securities upon exercise of warrants false 0 PAULSON INVESTMENT COMPANY LLC 5670 None None 10220 SW GREENBURG RD SUITE 380 PORTLAND OR OREGON 97223 All States false 1971001 1971001 0 false 11 149640 true 0 Issuance of "placement agent warrants" representing 85,100,000 ordinary shares. 0 false Akari Therapeutics Plc /s/ Rachelle Jacques Rachelle Jacques President and Chief Executive Officer of Issuer 2023-10-19